Wplyw niesteroidowych lekow przeciwzapalnych na czynnosc cialka zoltego

• Autorzy: Chrostowska M , Jaroszewski J. , Markiewicz W.

Warianty tytułu

EN

Effects of non-steroidal anti-inflammatory drugs on corpus luteum function

• Języki publikacji: PL

Abstrakty

EN

Non-steroidal anti-inflammatory drugs (NSAIDs) are the most widely used drugs in both human and veterinary medicine. NSAIDs inhibit the enzyme cyclooxygenase in the arachidonic acid cascade. This mechanism results in a reduced or blocked synthesis of prostaglandins. Eicosanoids are very important for reproduction and their inhibition by NSAIDs may cause disorders in the ovarian cycle. The article summarizes the latest knowledge about the effects of NSAIDs on corpus luteum function.

Słowa kluczowe

PL

funkcje wydzielnicze; prostaglandyny; niesteroidowe leki przeciwzapalne; cialko zolte

• Wydawca: -
• Czasopismo: Medycyna Weterynaryjna
• Rocznik: 2007
• Tom: 63
• Numer: 06
• Opis fizyczny: s.635-637,fot.,bibliogr.

Twórcy

autor

Chrostowska M

• Uniwersytet Warminsko-Mazurski w Olsztynie, ul.Oczapowskiego 13, 10-718 Olsztyn

autor

Jaroszewski J.

autor

Markiewicz W.

Bibliografia

• 1. Aba M. A., Kindahl H., Forsberg M., Quiroga M., Auza N.: Levels of progesterone and changes in prostaglandin F₂α release during luteolysis and early pregnancy in llamas and the effect of treatment with flunixin meglmine. Anim. Reprod. Sci. 2000, 59, 87-97.
• 2. Aiumlamai S., Odensvick K., Stabenfeldt G., Kindahl H.: Regulation of prostaglandin biosynthesis with flunixin meglumine in bovine species. J. Vet. Med. 1990, 37, 16-22.
• 3. Ake-Lopez R., Segura-Corrrea J. C., Quintal-Franco J.: Effect of flunixin meglumine on the corpus luteum and possible prevention of embryonic loss in Pelibuey ewes. Small Ruminant Research 2005, 59, 83-87.
• 4. Alila H. W., Corradino R. A., Hansel W.: A comparision of the effects of cyclooksygenase prostanoids on progesterone production by small and large bovine luteal cells. Prostaglandins 1988, 82, 259-270.
• 5. Arosh J. A., Banu S. K., Chapdelaine P., Madore E., Sirois J., Fortier M. A.: Prostaglandin biosynthesis, transport, and signaling in corpus luteum: a basis for autoregulation of luteal function. Endocrinology 2004, 145, 2551-2560.
• 6. Bennegard-Eden B., Hahlin M., Hamberger L.: Luteotropic effects of prostaglandin I₂ and D₂ on isolated human corpora luteum. Fertil. Steril. 1990, 54, 459-464.
• 7. Blatchley F. R., Donovan B. T., Horton E. W., Poyser N. L.: The release of prostaglandins and progestin into the utero-ovarian venous blood of guinea-pigs during the oestrous cycle and following oestrogen treatment. J. Physiol. 1972, 223, 69-88.
• 8. Chrostowska M., Barański W., Markiewicz W., Maślanka T., Jaroszewski J., Janowski T.: Influence of meloxicam on the ovulation in heifers. The 4th Symp. Soc. Biol. Reprod.&Joint Pol.-Jap. Seminar, Kraków 2005, s. 42.
• 9. Chrostowska M., Jaroszewski J. J., Maślanka T.: Wpływ niesteroidowych leków przeciwzapalnych na owulację i tworzenie ciałka żółtego. Medycyna Wet. 2005, 61, 865-869.
• 10. Cooke R. G., Homeida A. M.: Delayed luteolysis and suppression of the pulsatile release of oxytocin after indomethacin treatment in the goat. Res. Vet. Sci. 1984, 36, 48-51.
• 11. Davies I. J., Yoshinaga K., Ryan K. J.: The effects of combined dexamethasone and indomethacin treatment on the outcome of pregnancy in the rabbit. Biol. Reprod. 1976, 15, 551-554.
• 12. Hayes E. C., Rock J. A.: COX-2 inhibitors and their role in gynecology. Obstet. Gynecol. Surv. 2002, 57, 768-780.
• 13. Holt J. A.: Regulation of progesterone production in the rabbit corpus luteum. Biol. Reprod. 1989, 40, 201-208.
• 14. Homeida A. M., El-Eknah M. M.: Inhibition of luteal function by oxytocin antagonist in goats (Capra hircus). J. Reprod. Fertil. 1992, 94, 279-285.
• 15. Horton E. W., Poyser N. L.: Elongation of oestrous cycle in the guinea-pig following subcutaneous or intra-uterine administration of indomethacin. 1973, 49, 98-105.
• 16. Jaroszewski J. J., Skarżyński D. J., Hansel W.: Nitric oxide as a local mediator of prostaglandyn F₂α-induced regression in bovine corpus luteum: an in vivo study. Exp. Biol. Med. 2003, 228, 1057-1062.
• 17. Kraeling R. R., Rampacek G. B., Kiser T. E.: Corpus luteum function after indomethacin treatment during the estrous cycle and following hysterectomy in the gilt. Biol. Reprod. 1981, 25, 511-518.
• 18. Lau I. F., Saksena S. K., Chang M. C.: Effects of indomethacin, an inhibitor of prostaglandin biosynthesis, on the lengh of pseudopregnancy in rat and hamsters. Acta Endocrinol. 1975, 78, 343-348.
• 19. Lewis P. E., Warren J. E. Jr.: Effect of indomethacin on luteal function in ewes and heifers. 1977, 46, 763-767.
• 20. McCracken J. A., Glew M. E., Scaramuzzi R. J.: Corpus luteum regression induced by prostaglandin F₂α. J. Clin. Endocrinol. Metab. 1970, 30, 544-547.
• 21. McGuire W. J., Juengel J. L., Niswender G. D.: Protein kinase C second messenger system mediates the antisteroidogenic effects of prostaglandin F₂α in the ovine corpus luteum in vivo. Biol. Reprod. 1994, 51, 800-806.
• 22. Mellin T. N., Busch R. D.: Corpus luteum function in the ewe: effect of PGF₂α and prostaglandin synthetase inhibitors. Prostaglandins 1976, 12, 303-314.
• 23. Milvae R. A., Hansel W.: The effects of prostacyclin (PGI2) and 6-keto-PGF₁α on bovine plasma progesterone and LH concentrations. Prostaglandins 1980, 20, 641-647.
• 24. Milvae R. A., Hansel W.: Inhibition of bovine luteal function by indomethacin. J. Anim. Sci. 1985, 60, 528-531.
• 25. Nisewnder G. D., Juengel J. L., Silva P. J., Rollyson M. K., McIntush E. W.: Mechanisms controlling the function and life span of the corpus luteum. Physiol. Rev. 2000, 80, 1-29.
• 26. Odensvik K., Gustafsson H., Kindahl H.: The effect of oral administration of flunixin on luteolysis in heifers. Thierogenology 1997, 1, 148.
• 27. Roberts J. S., Barcikowski B., Wilson L. Jr., Skarnes R. C., McCracken J. A.: Hormonal and related factors affecting the release of PGF₂α from the uterus. J. Steroid. Biochem. 1975, 6, 1091-1097.
• 28. Saksena S. K., Shaikh S. A., Shaikh A. A.: Uterine and peripherial plasma F-prostaglandins correlated with peripherial progesterone in cyclic rats. Prostaglandins 1973, 4, 243-249.
• 29. Sakurei T., Tamura K., Okamoto S., Hara T., Kogo H.: Possible role of cyclooksygenase II in the acquisition of ovarian luteal function in rodents. 2003, 69, 835-842.
• 30. Sargent E. L., Baughman W. L., Novy M. J., Stouffer R. L.: Intraluteal infusion of a prostaglandin synthesis inhibitor, sodium meclofenamate, causes premature luteolysis in rhesus monkeys. Endocrinology 1988, 123, 2261-2269.
• 31. Shemesh M., Hansel W.: Levels of prostaglandin F (PGF) in bovine endometrium, uterine venous, ovarian arterial and jugular plasma during the estrous cycle. Proc. Soc. Exp. Biol. Med. 1975, 148, 123-126.
• 32. Souka A. R., Medhat M., Rahman H. A., Osman M., Sokkary H. E.: Effect of aspirin of the luteal phase of human menstrual cycle. Contraception 1984, 29, 181-188.
• 33. Stone S., Khamastha M. A., Nelson-Piercy C.: Nonsteroidal anti-inflammatory drugs and reversible female infertility: is there a link? Drug Saf. 2002, 25, 545-551.
• 34. Thorburn G. D., Cox R. J., Currie W. B., Restall B. J., Schneider W.: Prostaglandin F concentration in the utero-ovarian venous plasma of the ewe during the oestrous cycle. J. Endocrinol. 1972, 53, 231-232.
• 35. Zelinski-Wooten M. B., Sargent E. L., Molskness T. A., Stouffer R. L.: Disparate effects of the prostaglandin synthesis inhibitors, meclofenamate and flurbiprofen on monkey luteal tissue in vitro. Endocrinology 1990, 126, 1380-1387.